SCHEMBL7478427

SCHEMBL7478427

Cc1cc(=O)oc2c(C)c3c(cc12)CCO3

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.51
MAOB P27338 4/20 0.51
ALDH1A1 P00352 7/20 0.48
KDM4E B2RXH2 7/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
MAPK1 P28482 2/20 0.48
HTR2C P28335 1/20 0.48
ADORA2A P29274 1/20 0.48
CYP2A6 P11509 1/20 0.44
HPGD P15428 5/20 0.43
HSD17B10 Q99714 4/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
TSHR P16473 2/20 0.43
GAA P10253 4/20 0.43
LMNA P02545 4/20 0.43
MAPT P10636 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
BLM P54132 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9463827 0.91 MAOA (0.52) MAOAMAOBALDH1A1KDM4ECYP1A2
SCHEMBL9464056 0.77 MAOA (0.47) MAOAMAOBALDH1A1KDM4ECYP1A2
SCHEMBL9134783 0.74 MAOA (0.46) MAOAMAOBALDH1A1KDM4ECYP1A2
SCHEMBL11320599 0.72 MAOB (0.46) MAOAMAOBALDH1A1KDM4ECYP1A2
SCHEMBL4015156 0.71 ALDH2 (0.55) MAOAMAOBALDH1A1KDM4ECYP1A2
SCHEMBL9464226 0.71 CYP1A2 (0.52) MAOAMAOBALDH1A1KDM4ECYP1A2
SCHEMBL9132852 0.71 MAOA (0.46) MAOAMAOBALDH1A1KDM4ECYP1A2
SCHEMBL7483011 0.71 MAOA (0.43) MAOAMAOBALDH1A1KDM4ECYP1A2
SCHEMBL7822499 0.71 MAOA (0.43) MAOAMAOBALDH1A1KDM4ECYP1A2
SCHEMBL13021641 0.70 PARP1 (0.40) CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1144417-B1 4'-SUBSTITUTED-4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABOR INC (US) 2002-09-04 EP claimed
EP-1144417-A1 4'-SUBSTITUTED-4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2001-10-17 EP claimed
EP-1133498-A2 AMINO-AND MERCURIO-SUBSTITUTED 4', 5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2001-09-19 EP claimed
US-6255324-B1 MICROBIOCIDES; SKIN DISORDERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2001-07-03 US claimed
US-6177424-B1 ANTIPROLIFERATIVE AGENTS, MICROBIOCIDES, ANTISEPTICS HEINDEL NED D (US) 2001-01-23 US claimed
WO-2000032603-A1 4'-SUBSTITUTED-4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2000-06-08 WO claimed
WO-2000031081-A2 AMINO- AND MERCURIO-SUBSTITUTED 4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2000-06-02 WO claimed
EP-1144417-B1 4'-SUBSTITUTED-4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABOR INC (US) 2002-09-04 EP disclosed
EP-1144417-A1 4'-SUBSTITUTED-4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2001-10-17 EP disclosed
EP-1133498-A2 AMINO-AND MERCURIO-SUBSTITUTED 4', 5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2001-09-19 EP disclosed
US-6255324-B1 MICROBIOCIDES; SKIN DISORDERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2001-07-03 US disclosed
US-6177424-B1 ANTIPROLIFERATIVE AGENTS, MICROBIOCIDES, ANTISEPTICS HEINDEL NED D (US) 2001-01-23 US disclosed
WO-2000032603-A1 4'-SUBSTITUTED-4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2000-06-08 WO disclosed
WO-2000031081-A2 AMINO- AND MERCURIO-SUBSTITUTED 4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2000-06-02 WO disclosed